Goldman Sachs enters the final stretch before its October 13 Q3 results with a modest but clear rebuild in short positioning — a subtle shift worth watching against a backdrop of still-loose borrow conditions and a stock that has given back ground from its summer highs.
The short interest angle is not dramatic, but the direction is consistent. Shares short climbed roughly 11% over the past month to 2.2% of the free float — a level that remains low in absolute terms, but the week-on-week pace of accumulation (nearly 10%) is the fastest in recent history for this name. That said, the borrow market puts no real pressure on this positioning. Cost to borrow has actually eased over the past month, down about 27%, to just 0.23% — among the cheapest levels of the past six weeks. Availability is essentially unlimited, with 238 million shares available against a short position of roughly 7 million. There is no squeeze dynamic here; adding short exposure carries next to no friction. The ORTEX short score ticked up to 33.7 this week, its highest reading of the past two weeks, but remains in comfortably neutral territory. The options market corroborates this calm: the put/call ratio of 0.87 is barely above its 20-day average of 0.87, with a z-score close to zero. Neither the options nor the lending market is pricing in meaningful stress ahead of the print.
The Street is broadly constructive, though the most recent analyst activity — now roughly six weeks old — showed a mixed read on valuation after Q2's strong beat. Following the July 14 results, when the stock jumped 10% in a single session, most firms lifted targets. BofA raised its target to $1,300 and held its Buy, while Barclays moved to $1,245 at Overweight and Evercore ISI pushed to $1,210 at Outperform. The more cautious voices were notable too: JPMorgan held Neutral with a $955 target, sitting well below the current price of $1,029, and UBS maintained Neutral even after lifting to $1,150 in early August. The mean analyst target of $1,142 implies roughly 11% upside from here — meaningful headroom, but concentrated among the bulls. The bear case centres on trading revenue sensitivity to macro softness and ongoing regulatory headwinds; the bull case rests on the continued diversification into fee-based asset and wealth management, where Goldman's growth has been most consistent. On valuation, the stock trades at roughly 14x trailing earnings and 2.6x book — both multiples have drifted modestly lower over the past 30 days as the stock pulled back around 0.5% from its month-ago level.
The factor picture reflects that tug of war. Goldman's 90-day EPS momentum ranks in the 93rd percentile and its EPS surprise history lands at the 89th — the company has been a consistent beater. But 12-month forward EPS growth ranks just in the 21st percentile, suggesting the Street does not see the current earnings pace as durable. The dividend score is strong at 86, though dividend data in the snapshot is stale and should not be read as current yield guidance. Institutional ownership is anchored by the index stalwarts — BlackRock at 7.9%, Vanguard entities together above 9%, State Street at 6.2% — with incremental buying from JPMorgan Asset Management (which added roughly 313,000 shares as of September 1) the most notable recent flow. Insider activity has been modest and directionally negative: Goldman's Chief Administrative Officer made a series of open-market sales across July and August, totalling around 1,025 net shares, none flagged as being under a 10b5-1 plan. The CFO also sold in May. These are not alarming in isolation but add a small note of caution on the insider signal.
Among peers, the week was broadly weak. MS fell 1.3% on the week, IBKR dropped 1.7%, and JEF led the sector lower with a 4.2% decline — sharper than GS's own 0.9% weekly dip. The relative outperformance is modest, but Goldman has held up better than its pure-play capital markets peers this week.
With Q3 results on the calendar for October 13, the prior earnings pattern is the frame worth holding in mind: the July Q2 print produced a 10% single-day gain after a strong beat on trading and advisory revenues, though the five-day reaction moderated to about 3.8%. The April Q1 print saw a flat-to-slight decline. The question heading into October is whether the revenue mix — still weighted toward market-sensitive businesses despite the wealth management push — holds up in a quarter where macro uncertainty has remained elevated, and whether the current short rebuild is positioning for a more cautious number or simply reflects routine rebalancing before a major catalyst.
See the live data behind this article on ORTEX.
Open GS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
